New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common and aggressive type of primary brain cancer. The re…
Immune cells that eat bacteria in the body don’t stash them in specialized compartments as once thought, but turn them into critical nutrients that build proteins, create energy and keep the cells alive, according to a new study from scientists at the …
Immune cells that eat bacteria in the body don’t stash them in specialized compartments as once thought, but turn them into critical nutrients that build proteins, create energy and keep the cells alive, according to a new study.
A team of Yale School of Medicine infectious diseases researchers recently conducted an in-depth review of the literature on how one genus of viruses, known as flaviviruses, manipulates mitochondria to evade immune responses. Annually, more than 3 bill…
Swelling caused by brain cancer is a serious problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks a…
Painful monthly penicillin injections could be a thing of the past as Griffith University researchers, in collaboration with researchers at the University of New England, are investigating the benefits of an alternative therapy for children diagnosed w…
LMU researchers have shown that a particular type of immune cell acts more flexibly than previously thought—with the potential for new therapeutic approaches.
The new research reveals how a protein in brain cells may drive Parkinson’s onset — and offers a possible explanation for why Parkinson’s is much more common in men.
Researchers from the Organoid group at the Hubrecht Institute have found that specific gut cells, BEST4/CA7+ cells, regulate electrolyte and water balance in response to bacterial toxins that cause diarrhea. Their findings, published in Cell Stem Cell,…
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson’s disease. Their new research reveals how a protein in brain cells may drive Parkinson’s onset—and offers a possible explanation for why Park…
